Inspiration Biopharmaceuticals, Inc. (extinct)

Inspiration Biopharmaceuticals, Inc. (extinct)

Inspiration Biopharmaceuticals, Inc. (extinct)

Overview
Date Founded

2006

Headquarters

200 State Street,8th floor,Boston, MA 02109

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Biotechnology
IT Consulting & Services
Hospitals & Patient Services
Pharmaceuticals
Medical Support Services

Company Description

Inspiration Biopharmaceuticals, Inc. produces intravenous recombinant therapies and develops non-invasive applications. It offers its products for the hemophilia community. The company was founded by Scott Donnelly Martin and John Read Taylor, Jr. on April 28, 2006 and is headquartered in Boston, MA.

In The News
St. Louis Business Journal
October 17, 2014
Shopping spree?: Retailers, not everyone, expect strong season
Los Angeles Times
October 3, 2014
Firms' planned layoffs hit 14-year low
Los Angeles Times
September 19, 2014
Retailers ramping up holiday hiring efforts
Associated Press Financial Wire
September 18, 2014
Brighter economy driving up holiday hiring plans
Executives & Employees

Chief Executive Officer

Vice President, Process Sciences

Paths to Inspiration Biopharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Inspiration Biopharmaceuticals, Inc.
Recent Transactions
Details Hidden

Baxter International, Inc. purchases Ipsen Pharma SAS /OBI-1 Manufacturing Ops from Inspiration Biopharmaceuticals, Inc., Ipsen SA

Details Hidden

Inspiration Biopharmaceuticals, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onBaxter International, Inc. purchases Ipsen Pharma SAS /OBI-1 Manufacturing Ops from Inspiration Biopharmaceuticals, Inc., Ipsen SA

Investment Advisor

Advised onInspiration Biopharmaceuticals, Inc. raised money in a private placement transaction

Legal Advisor

Advised onBaxter International, Inc. purchases Ipsen Pharma SAS /OBI-1 Manufacturing Ops from Inspiration Biopharmaceuticals, Inc., Ipsen SA

Counsel

Advised onBaxter International, Inc. purchases Ipsen Pharma SAS /OBI-1 Manufacturing Ops from Inspiration Biopharmaceuticals, Inc., Ipsen SA

Legal Advisor

Advised onBaxter International, Inc. purchases Ipsen Pharma SAS /OBI-1 Manufacturing Ops from Inspiration Biopharmaceuticals, Inc., Ipsen SA

Legal Advisor

Advised onBaxter International, Inc. purchases Ipsen Pharma SAS /OBI-1 Manufacturing Ops from Inspiration Biopharmaceuticals, Inc., Ipsen SA

Investors
Details Hidden

Founder at Franklin College Switzerland

Details Hidden

Executive Vice President at Martin Midstream GP LLC

Details Hidden

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults and children; and Fortrans, a colon cleansing solution indicated for patients in preparation for endoscopic, radiological examinations or colonic surgery. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.